Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand

Benzer Materyaller

• Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand
  Yazar:: Aye, Phyu Sin, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10
  Yazar:: Elwood, J. Mark, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Use of Non-Cancer Medications in New Zealand Women at the Diagnosis of Primary Invasive Breast Cancer: Prevalence, Associated Factors and Effects on Survival
  Yazar:: Aye, Phyu Sin, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test
  Yazar:: Shepherd, Phillip, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Comparative outcomes of squamous and non-squamous non-small cell lung cancer (NSCLC) patients in phase II studies of ASA404 (DMXAA) – retrospective analysis of pooled data
  Yazar:: McKeage, Mark J, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)